S259: SAR444245, A NON-ALPHA IL2, RESCUES CHRONIC ANTIGEN- AND CAR-DRIVEN T-CELL DYSFUNCTION

Irtiza Sheikh(The University of Texas MD Anderson Cancer Center), Michael R. Green(Harvard University), Laura Powers(Sanofi (France)), Ahyun Choi(Sanofi (France)), Chaomei Shi(Sanofi (France)), Robin Meng(Sanofi (France)), Margot Cucchetti(Sanofi (France)), Julie-Ann Gavigan, Virna Cortez‐Retamozo(Vrije Universiteit Brussel), Patrick K. Reville(The University of Texas MD Anderson Cancer Center), Jared Henderson(The University of Texas MD Anderson Cancer Center), James Cao(Sanofi (Mexico)), Ingrid Sassoon(Sanofi (France)), Nathan Pate(Sanofi (Mexico)), Dinesh S. Bangari(Sanofi (United States)), Donald R. Shaffer(The University of Texas MD Anderson Cancer Center), Maria Agarwal(Sanofi (France)), Kelly Balko(Sanofi (France)), Katie Malley(Sanofi (Mexico)), Giovanni Abbadessa(Morristown Medical Center), Chizitara Okwuchi(The University of Texas MD Anderson Cancer Center), Bing Liu(Peking University Shenzhen Hospital), Rui Wang(First Affiliated Hospital of Zhengzhou University), Xiangming Li(The University of Texas MD Anderson Cancer Center), Yuan Zhang, Sukhvinder Sidhu(The University of Sydney), C. Le(The University of Texas MD Anderson Cancer Center), Jing Jiao, Xiaoyou Ying(Sanofi (France)), Tony Byers(The University of Texas MD Anderson Cancer Center), Estela Rojas(The University of Texas MD Anderson Cancer Center), Elamaran Meibalan(Harvard University), Robert Carrio, Qunyan Yu(Sanofi (France))
HemaSphere
August 1, 2023
Cited by 0


Related Papers